✦ LIBER ✦

INCIDENCE AND PREDICTORS OF STENT THROMBOSIS UP TO 7 YEARS FOLLOW-UP FOLLOWING DRUG-ELUTING STENT IMPLANTATION IN UNSELECTED PATIENTS WITH COMPLEX CORONARY LESIONS TREATED IN THE REAL-WORLD CLINICAL PRACTICE - A SUBANALYSIS FROM THE DRUG-ELUTING STENT IN THE REAL WORLD “DESIRE” REGISTRY

✍ Scribed by Costa, Ricardo A.; Sousa, Amanda; Moreira, Adriana; Ribamar Costa, J.; Maldonado, Galo; Cano, Manuel; Feres, Fausto; Mattos, Luiz A.; Staico, Rodolfo; Abizaid, Alexandre; Campos, Cantídio; Carballo, Mariana T.; Berwanger, Otávio; Eduardo Sousa, J.

Book ID: 123464389
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 75 KB
Volume: 55
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(10)61791-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VERY LOW RATES OF STENT THROMBOSIS UP TO

VERY LOW RATES OF STENT THROMBOSIS UP TO 10 YEARS FOLLOWING DRUG-ELUTING STENT IMPLANTATION IN THE REAL WORLD CLINICAL PRACTICE

✍ Ricardo A. Costa; Amanda Sousa; J. Ribamar Costa; Adriana Moreira; Galo Maldonad 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 223 KB

TCT-483 Predictors of Early Stent Thromb

TCT-483 Predictors of Early Stent Thrombosis After Implantation of Drug-Eluting Stents in Daily Clinical Practice - A Subanalysis of the Large, Prospective DESIRE (Drug-Eluting Stent In the REal World) Registry

✍ Costa, Ricardo A.; Damiani, Lucas P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 112 KB

TCT-40: Stent Thrombosis Free Survival u

TCT-40: Stent Thrombosis Free Survival up to 7 Years in Patients Undergoing Drug-Eluting Stent (DES) Implantation in the Real-World Clnical Practice

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 156 KB

TCT-281: Incidence And Predictors Of Maj

TCT-281: Incidence And Predictors Of Major Adverse Cardiac Events(mace) Following Drug-eluting Stents Implantation In Patients With Chronic Kidney Disease. Insights From The Desire (Drug-eluting Stents In The Real World) Registry

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Extended follow-up safety and effectiven

Extended follow-up safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: Two-year follow-up from the E-Five Registry

✍ Ian Meredith; Martin Rothman; Andrejs Erglis; Keyur Parikh; Chaim Lotan; for the 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

## Abstract Objectives: To present data from the cohort of patients in the all‐comers Endeavor zotarolimus‐eluting stent (ZES) registry (E‐Five) who underwent 2‐year follow‐up. Background: The Endeavor ZES has been shown to be safe and efficacious for treatment of single, de novo lesions in patient

TCT-415: Comparison On The Incidence Of

TCT-415: Comparison On The Incidence Of Late Thrombosis After Implantation Of Different Drug-eluting Stents In Patients With Real World Coronary Artery Disease -three-year Follow-up Results

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 200 KB